FAQs
Glossary

Close

FAQs

Why are some conditions more suitable for gene and cell therapies than others?

There is an approved treatment available for my condition - why can't I receive it?

How to look for approved medicines?

How are medicines developed and approved?

Close

Glossary

Adeno-associated virus (AAV)

Adult stem cells

Chimeric Antigen Receptor (CAR)

See full Glossary

ATMPs

Types of the 26 authorised ATMPs in the European Union (EU) — Fig. 1. Types of the 26 authorised ATMPs in the European Union (EU). (last updated: February 2024) The breakdown of the types of authorised ATMPs in the EU is the following: 17 GTMP (65%), 5 CTMP (19%), 3 TEP (12%), and 1 Comb. TEP (4%). Abbreviations: Comb. TEP: Combined Tissue Engineered Product; GTMP: Gene Therapy Medicinal Product; CTMP: Cell Therapy Medicinal Product; TEP: Tissue Engineered Product.

This page is currently under development. In the mean time, please see the subentry below:

ATMPs and Orphan medicinal products

Acknowledgements

Last updated: 16/05/2024

Valentin Brunel is deeply thanked for his support in the design of the figure.

Did you find the content on this page useful? If not, you can leave us a message so we can improve Send us your thoughts